746P Impact of adjuvant (AC)and neoadjuvant (NAC) chemotherapy in patients (pts) with soft tissue sarcoma (STS): A real-life exhaustive nationwide study (DEEPSARC)

Jean Yves Blay; V. Thevenet; Emmanuel Oger; F. Gouin; André Happe; E. Drezen; A. Le Cesne; M. Toulmonde; S. Bonvalot; F. Le Loarer; M. Karanian; Carine Ngo; Gonzague de Pinieux; Anne Gomez‐Mascard; Françoise Ducimetière; Claire Chemin-Airiau; Hugo Crochet; Noémie Huchet; N. Penel; S. Mathoulin

doi:10.1016/j.annonc.2024.10.779

Related publications

Article2022

<scp>CINSARC</scp> in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the <scp>ISG‐STS</scp> 1001 study

Anna Maria Frezza, Silvia Stacchiotti, Frédéric Chibon, Jean‐Michelle Coindre, Antoîne Italiano, Cleofe Romagnosa, Sílvia Bagué, Angelo Paolo Dei Tos, Luca Braglia, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Antonella Brunello, Jean Yves Blay, Robert Díaz Beveridge, Iwona Ługowska, Tom Lesluyes, Roberta Maestro, Domenico Franco Merlo, Paolo G. Casali, Alessandro Gronchi

Article2025

EE275 Economic Evaluation of Adjuvant Chemotherapy for Soft Tissue Sarcoma Using Linked NETSARC+ (French Registry) and SNDS (French National Health Data System) Real World Data: The Deepsarc Study

Lionel Perrier, Magali Morelle, Sylvie Bonvalot, Claire Chemin, Hugo Crochet, Anne Ducassou, Françoise Ducimetière, F. Gouin, André Happe, Noémie Huchet, François Le Loarer, Axel Le Cesne, C. Llacer, Simone Mathoulin-Pelissier, Pierre Méeus, Daniel Orbach, V. Thevenet, Maud Toulmonde, Gualter Vaz, Nicolas Penel, Jean Yves Blay

Article2023

A phase III randomized trial of neo-adjuvant chemotherapy in high-risk soft tissue sarcoma (ISG-STS 1001): Feasibility and activity of concurrent chemotherapy and radiation therapy.

Elena Palassini, Sara Pizzamiglio, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Giovanni Grignani, Antonella Brunello, Jean Yves Blay, Oscar Tendero, Robbie Beveridge, Antonio López–Pousa, Virginia Ferraresi, Iwona Ługowska, Valeria Fontana, Giuseppe Bianchi, Silvia Stacchiotti, Angelo Paolo Dei Tos, Paolo Verderio, Paolo G. Casali, Alessandro Gronchi

Article2020

Prognostic role of % changes in longest tumor diameter (LTD) in localized high-risk soft tissue sarcoma (STS) treated with neoadjuvant chemotherapy in a randomized clinical trial.

Silvia Stacchiotti, Carlo Morosi, Luca Braglia, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Antonella Brunello, Jean Yves Blay, Oscar Tendero, Robert Díaz Beveridge, Iwona Ługowska, Valeria Fontana, Emanuela Marchesi, Elena Palassini, Paolo Bruzzi, Domenico Franco Merlo, Paolo G. Casali, Alessandro Gronchi

Article2023

Histopathological response (HR) after neoadjuvant chemotherapy (ChT) for high-risk soft tissue sarcomas (STS): A planned analysis of the ISG-STS-1001 trial.

Sandro Pasquali, Paola Collini, Cleofé Romagosa, Jean Michel Coindre, Sara Pizzamiglio, Paolo Verderio, Marta Barisella, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Jean Yves Blay, Iwona A. Lugowska, Valeria Fontana, Marta Sbaraglia, Sílvia Bagué, Paolo De Tos, Paolo G. Casali, Alessandro Gronchi